Psilocybin Therapy Helps Clinicians Process COVID Despair
A groundbreaking study published in JAMA Network Open reveals that psilocybin-assisted psychotherapy significantly reduced depression among clinicians who provided front-line COVID-19 care. Compared to a placebo group, those who underwent the psilocybin therapy experienced much greater and more durable improvements in their mental health.
The study, led by Dr. Anthony Back, found that the therapy helped healthcare workers—many of whom faced intense burnout and emotional exhaustion—gain a new perspective, reconnect with themselves, and process their emotions in a compassionate way.
For doctors and nurses struggling with disillusionment and burnout, this research suggests that psilocybin therapy could offer a life-changing path to healing.
Congratulations Tony Back for your leadership to help healers heal!